Pfizer Pharma GmbH secures contract for Pharmaceutical products - drug discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredients Moroctocog alfa (Refacto(r)) and Nonacog alfa (Benefix(r))

Germany, Sept. 29 -- Germany based Pfizer Pharma GmbH has secured contract from AOK Baden-Wurttemberg for Pharmaceutical products - drug discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredients Moroctocog alfa (Refacto(r)) and Nonacog alfa (Benefix(r)). The value of the contract is worth 216000 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....